口腔癌
- 関
- oral cancer
WordNet
- of or relating to or affecting or for use in the mouth; "oral hygiene"; "an oral thermometer"; "an oral vaccine"
- an examination conducted by spoken communication (同)oral exam, oral_examination, viva voce, viva
- using speech rather than writing; "an oral tradition"; "an oral agreement" (同)unwritten
- a stage in psychosexual development when the childs interest is concentrated in the mouth; fixation at this stage is said to result in dependence, selfishness, and aggression
- of or involving the mouth or mouth region or the surface on which the mouth is located; "the oral cavity"; "the oral mucous membrane"; "the oral surface of a starfish"
- any malignant tumor derived from epithelial tissue; one of the four major types of cancer
PrepTutorEJDIC
- 『口頭の』,口述の(spoken) / 口の,口部の / 経口の
- 《選択を表し,語句・節を結んで》《肯定文・疑問文で》・・・『または』・・・,・・・か・・・ / 《否定文で》・・・も・・・もない / 《命令的表現の後で》『さもないと』 / 《前出の語を言い換えたり説明したりして》『すなわち』,言い換えれば
- がん,がん腫
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Nanoparticle delivery of HIF1α siRNA combined with photodynamic therapy as a potential treatment strategy for head-and-neck cancer.
- Chen WH1, Lecaros RL2, Tseng YC3, Huang L4, Hsu YC5.
- Cancer letters.Cancer Lett.2015 Apr 1;359(1):65-74. doi: 10.1016/j.canlet.2014.12.052. Epub 2015 Jan 14.
- Combination therapy has become a major strategy in cancer treatment. We used anisamide-targeted lipid-calcium-phosphate (LCP) nanoparticles to efficiently deliver HIF1α siRNA to the cytoplasm of sigma receptor-expressing SCC4 and SAS cells that were also subjected to photodynamic therapy (PDT). HIF
- PMID 25596376
- IL-1β Promotes Malignant Transformation and Tumor Aggressiveness in Oral Cancer.
- Lee CH1, Chang JS, Syu SH, Wong TS, Chan JY, Tang YC, Yang ZP, Yang WC, Chen CT, Lu SC, Tang PH, Yang TC, Chu PY, Hsiao JR, Liu KJ.
- Journal of cellular physiology.J Cell Physiol.2015 Apr;230(4):875-84. doi: 10.1002/jcp.24816.
- Chronic inflammation, coupled with alcohol, betel quid, and cigarette consumption, is associated with oral squamous cell carcinoma (OSCC). Interleukin-1 beta (IL-1β) is a critical mediator of chronic inflammation and implicated in many cancers. In this study, we showed that increased pro-IL-1β exp
- PMID 25204733
- Regulation and function of Myb-binding protein 1A (MYBBP1A) in cellular senescence and pathogenesis of head and neck cancer.
- George B1, Horn D2, Bayo P1, Zaoui K3, Flechtenmacher C4, Grabe N5, Plinkert P3, Krizhanovsky V6, Hess J7.
- Cancer letters.Cancer Lett.2015 Mar 28;358(2):191-9. doi: 10.1016/j.canlet.2014.12.042. Epub 2014 Dec 24.
- Myb-binding protein 1A (MYBBP1A) is a nucleolar protein implicated in stress response and carcinogenesis; however, its functional contribution to senescence remains elusive. In this study we show decreased MYBBP1A protein levels in tumor cells after treatment with etoposide, a potent inducer of DNA
- PMID 25543088
Japanese Journal
- Silicon Nanowire Biosensor for Highly Sensitive and Multiplexed Detection of Oral Squamous Cell Carcinoma Biomarkers in Saliva
- ZHANG Yulin,CHEN Rongmei,XU Lu [他]
- Analytical Sciences 31(2), 73-78, 2015-02
- NAID 40020357902
- 切除手術が行われたT4b口腔扁平上皮癌の治療成績に関する多施設共同後ろ向き研究
- 各種病変におけるpodoplanin発現とその意義
Related Links
- Oral Squamous Cell Carcinoma is a type of mouth cancer. It accounts 90 percent of oral cancer cases. It occurs on the lip, soft palate, gums, tongue, and other areas of the oral cavity and grows intensely in the surrounding tissues.
- Squamous cell carcinoma (SCC) is the most common carcinoma of the feline oral cavity. Carcinomas have also been reported in the associated parotid gland. There is no effective treatment, and the average duration of survival after ...
★リンクテーブル★
[★]
- 英
- oral cancer、oral carcinoma, carcinoma of oral cavity, cancer of the oral cavity
- 同
- 口腔がん
- 関
- 口腔腫瘍、舌癌
TNM分類
- ガイドライン1
- early T2 の用語を最大径が2 cm をこえ3 cm 以下の腫瘍に,late T2(もしくはadvanced T2)の用語を最大径が3 cm をこえ4 cm 以下の腫瘍に用いることがある。口腔癌においては有意な分類とする考えもある。(取扱指針2)
T
- TX:原発腫瘍の評価が不可能
- T0:原発腫瘍を認めない
- Tis:上皮内癌
- T1:最大径が2cm以下の腫瘍
- T2:最大径が2cmを超え、4cm以下の腫瘍
- T3:最大径が4 cmを超える腫瘍
- T4:
- T4a:骨髄質、舌深層の筋肉(外舌筋)、上顎洞、および顔面の皮膚に浸潤した腫瘍
- T4b:咀嚼間隙、翼突板または頭蓋底に浸潤した腫瘍、または内頸動脈を全周性に取り囲む腫瘍
N
- NX: 所属リンパ節の評価が不可能
- N0:所属リンパ節に転移なし
- N1:同側の単発性リンパ節転移で、その最大径が3cm以下
- N2:同側の単発性リンパ節転移で最大径が3cmを超え、6cm以下
- N2a:同側の単発性リンパ節転移で直径が3cmを超え6cm以下
- N2b:同側の多発リンパ節転移で最大径が6cm以下
- N2c:両側あるいは対側リンパ節転移で最大径が6cm以下
M
- MX:遠隔転移の評価が不可能
- M0:遠隔転移なし
- M1:遠隔転移あり
ガイドライン
- http://www.jsoms.or.jp/?page_id=755
取扱指針
- http://www.jsot.org/t-tumor.pdf
- http://www.jsot.org/guideline/guide-c&of.pdf
- http://www.jsot.org/guideline/guide-kagaku.pdf
[★]
⇔parenteral
- 関
- orally、p.o.、per os、peroral、perorally